NCT02149940
Feasibility of Pharmaceutical Interventions in Elderly Heart Failure Patients.
Sponsored by Universitaire Ziekenhuizen KU Leuven
Heart failure therapies (e.g. beta blockers) have been successful in decreasing mortality rates, as well as diminishing hospitalizations. Also, pharmacist collaboration has been shown to have a beneficial impact on heart failure related outcomes. Regardless, a high residual event rate is to be noted. In our pilot study, we wished to document whether a clinical pharmacist could still play a role in the heart failure management of an elderly inpatient heart failure population.
Inclusion Criteria: * 75 years or older * diagnosis of previous or new heart failure based on signs and symptoms as defined by the 'European Society of Cardiology guidelines on acute and chronic heart failure' * diagnosis had to be confirmed by a recent echocardiogram Exclusion Criteria: * not Dutch speaking * treatment restrictions had been applied on admission
University Hospitals Leuven
Leuven, Flemish Brabant, Belgium
Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.
Interested in this trial?
Express your interest and we'll connect you with the trial team.
Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.
Conditions